BOULDER, Colo.—Treehouse Eyes will share highlights of a large-scale retrospective study of pediatric myopia management patients at the upcoming Global Specialty Lens Symposium (GSLS) which will be held in Las Vegas, Jan. 19-22.
This retrospective, the CAMP (Clinical Algorithm for Myopia Progression) study, followed 342 children in myopia treatment in a real-world clinical setting, gathering both refractive error and axial length data.
The study followed all children examined with at least one year of data in various treatments through three years and showed the effectiveness of its proprietary Treehouse Vision System (TVS) clinical protocol.
Among the findings, use of the Treehouse Vision System protocol showed that 78 percent of children in treatment showed minimal change (<= 0.25D/year) in cycloplegic spherical equivalent refractive error (CSER) after one year in treatment.
Importantly, the CAMP study provides real-world data on the effectiveness of various treatments for myopia in children, including optical and pharmacological interventions.
Overall, the TVS treatment approach was found to be highly effective in a large range of children, most of whom were at considerable risk for myopic progression based on their age, young age at onset of myopia, parental myopia status, and ethnicity, the survey reported.
Dr. Kevin Chan, OD, FAAO, senior clinical director for Treehouse Eyes and lead author said, “It is very satisfying to be a part of this pioneering study and demonstrate the impact a good clinical protocol can have in reducing myopia progression.
Our clinical treatment algorithm demonstrated excellent control of CSER and axial length (AL) as compared to age and ethnicity matched virtual myopic control group data.
"Custom orthokeratology and soft multifocal contact lenses showed the lowest amount of change over time. The treatment protocol was successful for modifying the treatment for myopic progression in a high-risk group of children and provides a model that can be applied in other practice settings.
“Results varied significantly, indicating customization of treatments is warranted to optimize results. I look forward to sharing a poster on our findings at the upcoming GSLS meeting.”
Dr. Earl Smith, OD PhD, another author of the CAMP study, stated, “The CAMP study is pivotal to advance our understanding of how different treatments impact myopia progression in a real-world clinical setting.
With a sample size of 342 mostly high-risk children followed for multiple years with refractive error and axial length measurements, this study will help us develop a new protocol to customize treatments for even better results.
These children were treated with a variety of methods and some with a combination of atropine and a contact lens, so this is pioneering work to help move us forward as myopia treatment becomes standard of care.”
Treehouse Eyes CEO Matt Oerding said, “I’m proud of the groundbreaking work our team has done to help understand the effectiveness of different treatments to slow the progression of childhood myopia. We’ve demonstrated fantastic real-world clinical results in a large group of children with our existing Treehouse Vision System clinical protocol.
"I’m excited to use the results of the CAMP study to make our current proprietary protocol for clinical decision making even easier and achieve even better results with a customized treatment approach.
As the leading providers of myopia treatment, we have an obligation to continue to lead from the front to help more children get effective treatment for their myopia,” Oerding said.
The mission of Treehouse Eyes is to give children a better vision for life. As the first and only health care business dedicated exclusively to treating myopic children, Treehouse Eyes’ doctors have helped thousands of children have better vision and reduce their risk of serious eye diseases associated with myopia.
Treehouse Eyes providers have the latest equipment and clinical training to diagnose myopia and recommend a customized treatment plan for each child to get the best results.
Treehouse Eyes now has more than 50 locations in 21 states across the country, making Treehouse Eyes the largest myopia management provider in the country.
As the leader and expert in myopia management, Treehouse Eyes guides eye doctors to fast track success in managing myopia for kids through their proprietary algorithm and proven playbook to simplify clinical decision-making, and ongoing marketing and practice support to ensure long-term success, the company said.